- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01241812
Biomarkers and Knee Osteoarthritis
October 10, 2017 updated by: Michael Hunt, University of British Columbia
Biomarkers and Knee Osteoarthritis: Associations With Joint Load and Effects of Exercise
High joint load during walking has been linked to cartilage degradation.
Biomarkers, found in the blood and urine, are protein fragments released after cartilage degradation characteristic of OA.
They have the potential to enable direct and immediate disease state monitoring and identification of early cartilage changes.
Little is known about the association of biomarkers with joint load or if exercise aimed at reducing joint load changes biomarker levels, thus reducing the risk of OA progression.
This study will provide novel information on these relationships and will guide future intervention studies.
The investigators hypothesize that certain biomarkers will be highly correlated with joint loading during walking and that the levels of these biomarkers in the blood and urine will decrease following an exercise intervention aimed at cartilage unloading.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Participants will be tested twice (baseline and 11 weeks later) where they will undergo gait and strength analyses by the same blinded assessor, complete self-report questionnaires, and have blood and urine samples drawn.
Participants will then be randomized into either: (i) exercise; or (ii) usual care (no additional treatment).
Those in the exercise group will complete 10-weeks of strengthening targeting lower limb muscles.
Once weekly, they will consult with the study physiotherapist (MAH) at UBC to ensure proper performance and safe progression of exercises.
Participants will be given cuff weights and resistance bands to complete exercises at home five times per week.
Exercise compliance will be monitored using log books.
All participants will be encouraged to maintain their usual treatment regimen (except for exercises completed by the exercise group), but will document any unexpected alterations such as medication changes or physician visits.
Study Type
Interventional
Enrollment (Actual)
17
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada
- University of British Columbia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age greater than 50 years (to meet the American College of Rheumatology clinical definition of OA)
- radiographically confirmed knee OA in the medial compartment of the tibiofemoral joint
- knee pain during walking greater than 3/10 (based on an 11-point scale; 0 = "no pain", 10 = "maximal pain") on most days of the previous month
- predominance of pain/tenderness over the medial (inside) region of the knee
Exclusion Criteria:
- articular cartilage degradation in the lateral tibiofemoral compartment greater than the medial (medial compartment OA is more common than lateral and the KAM is a validated measure of medial compartment loading only)
- currently in a structured exercise program
- medical condition precluding exercise
- inflammatory arthritic condition
- history of knee replacement surgery
- recent use of corticosteroids (oral or via injection)
- unable to attend exercise training sessions at UBC
- pain originating predominantly from the patellofemoral joint
- inability to ambulate without a gait aid
- non-English speaking (questionnaires are in English and must be completed by the study participant only)
- recent (within 6 months) arthroscopic knee surgery
- significant hip or back pain (limits the ability to perform the testing and exercises)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: B
|
|
Experimental: A.
10 weeks of partially supervised lower limb muscle strengthening targeting the following muscles groups: quadriceps, hamstrings, hip abductors.
|
Participants in the exercise group will receive a lower limb strengthening program consisting of 6 exercises targeting the quadriceps, hamstrings, and hip abductor groups.
They will perform these exercises at home 4 times per week (3 sets of 10 repetitions per exercise).
Over the course of the intervention, each participant will consult with the physiotherapist a total of 5 times (once per week in weeks: 1,2,3,5, and 8) to ensure proper performance of exercises and safe progression of resistance.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Serum levels of biomarkers (COMP, HA, C2C, CP2) measured at baseline and 11 weeks
Time Frame: 11 weeks
|
11 weeks
|
Urinary levels of biomarkers (CTX-2, C2C) measured at baseline and 11 weeks
Time Frame: 11 weeks
|
11 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Knee joint loading during walking (external knee adduction moment) measured at baseline and 11 weeks
Time Frame: 11 weeks
|
11 weeks
|
Self-reported pain and physical function (WOMAC) measured at baseline and 11 weeks.
Time Frame: 11 weeks
|
11 weeks
|
Isometric muscle strength (hamstrings, quadriceps, hip abductors) measured at baseline and 11 weeks
Time Frame: 11 weeks
|
11 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Michael A. Hunt, PT, PhD, University of British Columbia
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2010
Primary Completion (Actual)
September 1, 2011
Study Completion (Actual)
September 1, 2011
Study Registration Dates
First Submitted
November 12, 2010
First Submitted That Met QC Criteria
November 15, 2010
First Posted (Estimate)
November 16, 2010
Study Record Updates
Last Update Posted (Actual)
October 12, 2017
Last Update Submitted That Met QC Criteria
October 10, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H10-01492
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Tianjin XinChen-Techfields Pharma Co., LTD.Completed
-
Eun Jung KimMinistry of Health & Welfare, Korea; Semyung UniversityUnknownOsteoarthritis KneeKorea, Republic of
-
Novartis PharmaceuticalsRecruitingSymptomatic Knee OsteoarthritisUnited States, Spain, Hungary, Argentina, Germany, Slovakia, Czechia, Belgium, Romania
-
University of BathUniversity of Oxford; 3D Metal Printing Ltd; Versus ArthritisRecruitingMedial Knee OsteoarthritisUnited Kingdom
Clinical Trials on Lower limb muscle strengthening
-
Muğla Sıtkı Koçman UniversityCompleted
-
Riphah International UniversityCompletedCerebral Palsy,DiplegicPakistan
-
University Hospital, BrestCompleted
-
University of OttawaCompletedHyperthermia | Aging | Heat Stress | Weather; Heat | Heat SyncopeCanada
-
Singapore General HospitalRecruitingPeripheral Arterial Disease | Critical Limb IschemiaSingapore
-
Faculdade de Ciências Médicas da Santa Casa de...CompletedLow Back Pain, Mechanical | Low Back Pain, Postural | Lower Back Pain Chronic | Low Back Pain, Posterior CompartmentBrazil
-
Karolinska InstitutetRecruitingUnilateral Lower Limb SuspensionSweden
-
Chinese University of Hong KongUnknown
-
Université de MontréalCanadian Institutes of Health Research (CIHR)Completed
-
Centre d'Investigation Clinique et Technologique...CompletedFatigue | Spastic Gait | Fall Due to Failure of SupportFrance